Trials / Completed
CompletedNCT01604408
A Study in Older Participants Who Have Fallen and Have Muscle Weakness
A Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 Versus Placebo in Older Patients Who Have Fallen Recently and Have Muscle Weakness
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 201 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 75 Years
- Healthy volunteers
- Not accepted
Summary
LY2495655 is an investigational drug being tested for muscle wasting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | LY2495655 | Administered SC |
| DRUG | Placebo | Administered SC |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2013-09-01
- Completion
- 2013-12-01
- First posted
- 2012-05-23
- Last updated
- 2018-04-25
- Results posted
- 2018-04-25
Locations
22 sites across 6 countries: United States, Argentina, Australia, France, Germany, Sweden
Source: ClinicalTrials.gov record NCT01604408. Inclusion in this directory is not an endorsement.